XUZHOU KANGSHARE HEALTH TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

XUZHOU KANGSHARE HEALTH TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 11 (Environmental Control) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include KANG SHARE. The owner is based in Jiangsu Province.

No. 8-19, Gongye 3rd Rd, Peinan Ind Zone

Jiangsu Province 221637 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

XUZHOU KANGSHARE HEALTH TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

11
Environmental Control (1 filing)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

Frequently Asked Questions

How many trademarks does XUZHOU KANGSHARE HEALTH TECHNOLOGY CO., LTD. have?

XUZHOU KANGSHARE HEALTH TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does XUZHOU KANGSHARE HEALTH TECHNOLOGY CO., LTD. file in?

XUZHOU KANGSHARE HEALTH TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 11 (Environmental Control). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.

What are XUZHOU KANGSHARE HEALTH TECHNOLOGY CO., LTD.'s most well-known trademarks?

XUZHOU KANGSHARE HEALTH TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as KANG SHARE. These are among 1 currently registered trademark in the portfolio.

What is XUZHOU KANGSHARE HEALTH TECHNOLOGY CO., LTD.'s trademark registration success rate?

XUZHOU KANGSHARE HEALTH TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.